Investigational Site Number 752001

Stockholm 17176

0 studies enrolling now · 7 studies all time

What they study most

Diabetes Mellitus, Type 2, Hematopoietic Neoplasm, Multiple Sclerosis Relapse, Nasal Polyps, Relapsing-remitting Multiple Sclerosis, Type 2 Diabetes, Venous Thromboembolism

Studies at this site

• Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis — Completed
• An Evaluation of Dupilumab in Patients With Nasal Polyposis And Chronic Symptoms Of Sinusitis — Completed
• Efficacy and Safety of Lixisenatide Versus Placebo on Top of Basal Insulin and/or Oral Antidiabetic Treatment in Older Type 2 Diabetic Patients — Completed
• Efficacy and Safety of Vatelizumab in Patients With Relapsing-Remitting Multiple Sclerosis — Stopped early
• Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis and Treated With Interferon-beta — Stopped early
• Efficacy Assessment of Insulin Glargine Versus LiraglutidE After Oral Agents Failure — Completed
• Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgery — Completed